In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more


Vascular biology is the key to understanding the mechanisms of atherosclerosis, which remains the most frequent cause of cardiovascular disease. As such, atherosclerosis and vascular biology are inseparably linked in our search for better means of diagnosis, prevention and treatment of atherosclerosis. Novel tools and findings will further advance our knowledge and support our quest to reduce cardiovascular disease burden.

The Working Group on Atherosclerosis and Vascular Biology
is the ESC’s platform where clinical, basic and translational scientists come together to discuss and elaborate on novel findings and targets to bring clinical demands to the bench and new therapies to the patient.

The Working Group offers talented young scientists and clinicians a vibrant environment to flourish and exchange scientific ideas with colleagues from all over the world.

Prof. Paul EVANS (UK)
Chairperson 2016-2018